At the news
? NEUTRALIMPACT 3/10 144 filed Apr 13, 2026 at 16:22 ET
Jon Congleton, an officer of Mineralys Therapeutics, filed a Form 144 to notify intent to sell 15,730 shares of common stock, which vested on April 10, 2026, as part of a restricted share unit award. The sale is planned through Merrill Lynch on Nasdaq.
- Jon Congleton, an officer, intends to sell 15,730 shares of MLYS common stock.
- Shares were acquired on April 10, 2026, due to vesting of restricted share units granted under the company's equity compensation plan.
- The filing was submitted on April 13, 2026, with Merrill Lynch listed as the broker.
- No sales have occurred yet; this is a notice of proposed sale.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access